COM:ERYTECH
PHAXIAM Therapeutics
- Stock
Last Close
0.80
28/06 15:35
Market Cap
48.66M
Beta: -
Volume Today
27.49K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 168.30K - | 182.18K 8.25% | 155.50K 14.64% | 160.50K 3.22% | 786K 389.72% | 877K 11.58% | 179K 79.59% | 634K - | 2.48M 290.77% | ||
average payables | 1.75M - | 2.88M 64.19% | 4.25M 47.73% | 6.45M 51.79% | 12.37M 91.59% | 10.86M 12.14% | 4.89M 54.99% | 3.60M 26.47% | 2.02M 43.72% | 2.62M 29.48% | |
average receivables | 1.90M - | 4.02M 110.84% | 5.16M 28.37% | 2.24M 56.57% | 53K 97.63% | 2.93M 5,422.64% | 5.08M 73.52% | 4.28M 15.69% | 3.38M 21.03% | 1.34M 60.39% | |
book value per share | 6.10 - | 6.77 11.09% | 4.46 34.10% | 10.11 126.57% | 8.12 19.74% | 4.77 41.24% | 1.44 69.74% | 0.96 33.20% | 0.76 21.47% | 5.46 620.40% | |
capex per share | -0.07 - | -0.04 46.11% | -0.22 467.28% | -0.09 57.07% | -0.79 742.22% | -1.12 41.53% | -0.06 94.47% | -0.01 79.73% | -0.00 78.21% | 0.05 1,786.47% | |
capex to depreciation | -1.52 - | -0.93 38.71% | -4.12 341.10% | -3.17 22.94% | -17.85 462.18% | -4.78 73.24% | -0.23 95.21% | -0.06 75.76% | -0.03 47.26% | 0.13 561.69% | |
capex to operating cash flow | 0.06 - | 0.02 68.31% | 0.10 438.73% | 0.07 31.22% | 0.36 429.78% | 0.46 28.33% | 0.02 95.25% | 0.01 76.21% | 0.00 49.02% | -0.01 431.96% | |
capex to revenue | 0.16 - | ||||||||||
cash per share | 6.30 - | 6.56 4.17% | 4.72 28.11% | 10.34 119.34% | 7.49 27.57% | 4.08 45.53% | 2.42 40.74% | 1.44 40.32% | 1.25 13.23% | 2.23 78.18% | |
days of inventory on hand | 10.95 - | 5.62 48.64% | 2.68 52.27% | 2.52 6.00% | 15.22 503.44% | 2.50 83.56% | |||||
days payables outstanding | 115.06 - | 124.38 8.10% | 89.44 28.09% | 115.77 29.44% | 181.64 56.90% | 35.48 80.46% | 29.83 15.93% | ||||
days sales outstanding | 28.35 - | ||||||||||
debt to assets | 0.02 - | 0.01 29.52% | 0.06 377.16% | 0.01 77.14% | 0.01 17.40% | 0.12 889.95% | 0.34 186.53% | 0.38 11.33% | 0.30 22.08% | 0.20 32.88% | |
debt to equity | 0.02 - | 0.02 30.07% | 0.08 435.36% | 0.02 80.50% | 0.01 11.53% | 0.17 1,089.90% | 1.03 526.52% | 1.11 7.40% | 0.58 47.99% | 0.40 31.07% | |
dividend yield | |||||||||||
earnings yield | -0.06 - | -0.08 50.76% | -0.20 137.93% | -0.10 49.42% | -0.34 237.44% | -0.52 52.92% | -0.56 7.54% | -1.07 91.02% | -0.02 98.13% | -1.18 5,773.41% | |
enterprise value | 122.87M - | 133.89M 8.96% | 74.92M 44.05% | 149.16M 99.11% | -20.24M 113.57% | 61.13M 402.01% | 113.73M 86.04% | 41.90M 63.16% | -13.85M 133.04% | 22.75M 264.28% | |
enterprise value over ebitda | -14.29 - | -9.09 36.37% | -3.49 61.64% | -4.52 29.62% | 0.54 111.96% | -1.00 284.86% | -1.67 67.38% | -0.88 47.25% | 0.61 169.09% | -0.99 262.59% | |
ev to operating cash flow | -16.97 - | -9.18 45.89% | -4.25 53.69% | -6.04 41.98% | 0.52 108.54% | -1.41 373.84% | -2.20 55.79% | -0.74 66.43% | 0.44 159.05% | -0.93 313.62% | |
ev to sales | 17.15 - | ||||||||||
free cash flow per share | -1.30 - | -2.13 63.66% | -2.43 13.67% | -1.47 39.34% | -2.98 102.70% | -3.54 18.60% | -2.87 18.71% | -2.41 16.22% | -1.03 57.37% | -5.25 411.18% | |
free cash flow yield | -0.05 - | -0.08 72.45% | -0.18 112.61% | -0.08 54.95% | -0.48 500.00% | -0.53 10.63% | -0.40 23.40% | -1.14 180.98% | -2.80 146.40% | -1.24 55.88% | |
graham net net | 5.77 - | 6.36 10.29% | 3.97 37.62% | 9.58 141.32% | 6.29 34.32% | 2.49 60.35% | -0.33 113.43% | -0.28 17.27% | 0.61 321.53% | -2.70 539.44% | |
graham number | 14.38 - | 18.14 26.07% | 16.60 8.45% | 20.62 24.22% | 19.73 4.35% | 19.36 1.85% | 11.38 41.23% | 7.02 38.32% | 0.35 94.96% | 24.78 6,901.83% | |
income quality | 0.82 - | 0.97 18.85% | 0.80 17.22% | 0.74 8.35% | 1.03 39.45% | 0.69 32.72% | 0.71 2.08% | 1.06 49.56% | 139.32 13,101.99% | 1.04 99.25% | |
intangibles to total assets | 0.00 - | 0.00 53.46% | 0.00 8.37% | 0.00 78.18% | 0.01 3,375.05% | 0.01 47.07% | 0.01 44.02% | 0.00 96.93% | 0.00 51.42% | 0.60 553,199.95% | |
interest coverage | -1.32K - | -3.12K 136.89% | -5.60K 79.59% | -2.06K 63.21% | -4.85K 135.38% | -41.80 99.14% | -12.86 69.24% | -26.43 105.61% | -2.05 92.25% | -120.71 5,788.92% | |
interest debt per share | 0.13 - | 0.10 22.45% | 0.36 250.80% | 0.16 55.65% | 0.11 29.06% | 0.87 671.66% | 1.78 104.39% | 1.16 34.91% | 0.48 58.55% | 2.21 359.91% | |
inventory turnover | 33.34 - | 64.92 94.72% | 135.99 109.49% | 144.67 6.38% | 23.97 83.43% | 145.79 508.11% | |||||
invested capital | 0.02 - | 0.02 30.07% | 0.08 435.36% | 0.02 80.50% | 0.01 11.53% | 0.17 1,089.90% | 1.03 526.52% | 1.11 7.40% | 0.58 47.99% | 35.84M 6,203,960,009.09% | |
market cap | 159.09M - | 178.81M 12.40% | 109.70M 38.65% | 331.84M 202.52% | 112.11M 66.22% | 120.18M 7.20% | 130.73M 8.78% | 50.23M 61.58% | 11.38M 77.35% | 19.95M 75.40% | |
net current asset value | 34.74M - | 46.06M 32.56% | 33.20M 27.91% | 177.73M 435.26% | 127.67M 28.17% | 48.60M 61.94% | -4.23M 108.71% | -3.88M 8.41% | 20.31M 624.10% | -9.48M 146.66% | |
net debt to ebitda | 4.21 - | 3.05 27.57% | 1.62 46.92% | 5.54 241.94% | 3.54 36.13% | 0.97 72.69% | 0.25 74.10% | 0.18 29.89% | 1.11 533.60% | -0.12 110.95% | |
net income per share | -1.51 - | -2.16 43.07% | -2.74 27.20% | -1.87 31.90% | -2.13 14.00% | -3.49 63.93% | -3.99 14.13% | -2.27 43.04% | -0.01 99.68% | -5.00 67,953.37% | |
operating cash flow per share | -1.23 - | -2.10 70.05% | -2.21 5.30% | -1.38 37.58% | -2.19 58.98% | -2.41 10.29% | -2.81 16.50% | -2.40 14.82% | -1.02 57.26% | -5.20 408.03% | |
payables turnover | 3.17 - | 2.93 7.49% | 4.08 39.06% | 3.15 22.74% | 2.01 36.26% | 10.29 411.89% | 12.24 18.95% | ||||
receivables turnover | 12.87 - | ||||||||||
research and ddevelopement to revenue | 8.23 - | ||||||||||
return on tangible assets | -0.22 - | -0.28 29.86% | -0.49 72.07% | -0.17 64.80% | -0.23 33.87% | -0.53 131.03% | -0.92 72.87% | -0.81 12.25% | -0.00 99.38% | -1.16 23,119.12% | |
revenue per share | 0.28 - | ||||||||||
roe | -0.25 - | -0.32 28.79% | -0.61 93.04% | -0.18 69.94% | -0.26 42.04% | -0.73 178.97% | -2.76 277.14% | -2.35 14.74% | -0.01 99.59% | -0.92 9,346.63% | |
roic | -0.24 - | -0.32 33.09% | -0.58 78.22% | -0.17 71.06% | -0.30 76.37% | -0.57 92.98% | -1.06 86.35% | -0.97 8.59% | 0.05 105.53% | -0.63 1,268.12% | |
sales general and administrative to revenue | 7.74 - | ||||||||||
shareholders equity per share | 6.10 - | 6.77 11.09% | 4.46 34.10% | 10.11 126.57% | 8.12 19.74% | 4.77 41.24% | 1.44 69.74% | 0.96 33.20% | 0.76 21.47% | 5.46 620.40% | |
stock based compensation to revenue | 0.52 - | ||||||||||
tangible asset value | 35.79M - | 47.07M 31.51% | 35.58M 24.41% | 181.37M 409.73% | 143.99M 20.61% | 84.96M 41.00% | 25.95M 69.45% | 22.83M 12.02% | 23.48M 2.85% | -5.37M 122.88% | |
tangible book value per share | 6.09 - | 6.77 11.04% | 4.46 34.12% | 10.11 126.87% | 8.03 20.61% | 4.74 41.00% | 1.41 70.20% | 0.96 31.73% | 0.76 21.43% | -1.14 251.13% | |
working capital | 35.27M - | 46.31M 31.30% | 36.19M 21.86% | 179.96M 397.32% | 129.26M 28.17% | 61.70M 52.26% | 20.29M 67.12% | 20.04M 1.19% | 30.96M 54.45% | 955K 96.91% |
All numbers in EUR (except ratios and percentages)